Clinical Trial Update: Dolutegravir Renal Impairment Study [Phase 1]

View source ↗

Summary

A Phase 1 renal impairment study of dolutegravir has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Tivicay (dolutegravir)

Snippet

Sponsor: ViiV Healthcare | Conditions: Infection, Human Immunodeficiency Virus | Phase 1 | Status: COMPLETED